TD Cowen started coverage on shares of Anteris Technologies Global (NASDAQ:AVR – Get Free Report) in a report issued on Tuesday, MarketBeat Ratings reports. The firm set a “buy” rating and a $15.00 price target on the stock. TD Cowen’s price objective indicates a potential upside of 166.43% from the company’s previous close.
A number of other research analysts also recently weighed in on AVR. Cantor Fitzgerald initiated coverage on shares of Anteris Technologies Global in a research report on Tuesday. They issued an “overweight” rating and a $9.00 price objective for the company. Barclays assumed coverage on shares of Anteris Technologies Global in a research note on Tuesday. They set an “overweight” rating and a $22.00 price objective for the company.
Read Our Latest Stock Analysis on AVR
Anteris Technologies Global Price Performance
About Anteris Technologies Global
Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.
Recommended Stories
- Five stocks we like better than Anteris Technologies Global
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Investing in Construction Stocks
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Investing in Commodities: What Are They? How to Invest in Them
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for Anteris Technologies Global Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anteris Technologies Global and related companies with MarketBeat.com's FREE daily email newsletter.
